R&D Closed and Collaborative: Mergers, acquisitions, and partner... As we head further into H2, a final look back to the summer’s industry mergers and acquisiti
R&D Changing Faces – Pharma and biotech September 2024 Welcome to the September edition of Changing Faces.
R&D Closed and Collaborative: Mergers, acquisitions, and partner... Summer’s stretch having drawn out a longer return to our round-ups, as the days shorten and we firmly enter autumn, pharmaphorum takes a look back at the industry
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.
Patients 5 patient travel strategies to impact enrolment diversity in... According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden
R&D Supply chain resilience in pharma: Delivering consistency am... In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.
Digital AI, start-ups, and the future of human health: AION Labs’ Ma... In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
